Minoxidil, a vasodilator medication known for its ability to slow or stop hair loss and promote
hair regrowth, was first introduced, exclusively as an oral drug, to treat high blood pressure …

Male and female pattern hair loss affects a large percentage of the population, and patients
frequently present for treatment of this to their dermatologist. Here we review the many …

This new edition of a highly acclaimed standard reference has been restructured for greater
practical usefulness, to follow the clinical setting: it meticulously describes and illustrates all …

Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50% of the
male population. AGA is an androgen-related condition in genetically predisposed …

• A 1% minoxidil topical solution was used to treat 48 patients with alopecia areata, ie, 24
patients with patchy disease and 24 patients with alopecia totalis or alopecia universalis …

One-hundred twenty-six healthy men with early male pattern baldness completed a 12-
month double-blind, controlled trial of 2% and 3% topical minoxidil. Subjects were initially …

Minoxidil, a potent vasodilator, stimulates the growth of terminal hair from vellus or
miniaturized follicles in balding scalp. To study minoxidil's action on isolated follicles we …

Thirty-one men with androgenetic alopecia completed 4½ to 5 years of therapy with 2% and
3% topical minoxidil. Hair regrowth with topical minoxidil tended to peak at 1 year with a …

• A randomized double-blind trial of topical minoxidil therapy was carried out on 56 patients
with hereditary male pattern baldness. The subjects selected were required to have a …

Topical all-trans-retinoic acid (tretinoin) alone and in combination with 0.5% minoxidil has
been tested for the promotion of hair growth in 56 subjects with androgenetic alopecia. After …